Jackie Szymonifka

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

Saad Z. Usmani, Christoph Heuck, Alyson E. Mitchell et al. · Haematologica · 2012 · 389 citations · Full text

Medicine, Hematology, Oncology +17

FOLFIRINOX in Locally Advanced Pancreatic Cancer: The Massachusetts General Hospital Cancer Center Experience

Jason E. Faris, Lawrence S. Blaszkowsky, Shaunagh McDermott et al. · The Oncologist · 2013 · 277 citations · Full text

Medicine, Oncology, Surgery +17

Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker

Dennis C. Sgroi, Erin Carney, Elizabeth Zarrella et al. · JNCI Journal of the National Cancer Institute · 2013 · 232 citations · Full text

Medicine, Oncology, Pharmacology +17

Head-to-Head Comparison of Serial Soluble ST2, Growth Differentiation Factor-15, and Highly-Sensitive Troponin T Measurements in Patients With Chronic Heart Failure

Hanna K. Gaggin, Jackie Szymonifka, Anju Bhardwaj et al. · JACC Heart Failure · 2014 · 227 citations

Medicine, Cardiology, Clinical Cardiology +11

Identification of Three Rheumatoid Arthritis Disease Subtypes by Machine Learning Integration of Synovial Histologic Features and <scp>RNA</scp> Sequencing Data

Dana E. Orange, Phaedra Agius, Edward F. DiCarlo et al. · Arthritis & Rheumatology · 2018 · 214 citations · Full text

Medicine, Molecular Biology, Pathology +17